- Report
- February 2024
- 120 Pages
Asia Pacific
From €4378EUR$4,950USD£3,780GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4378EUR$4,950USD£3,780GBP
- Report
- December 2021
- 191 Pages
Global
From €3935EUR$4,450USD£3,398GBP
- Report
- April 2023
- 120 Pages
Global
From €4201EUR$4,750USD£3,627GBP
- Report
- April 2023
- 120 Pages
Global
From €4201EUR$4,750USD£3,627GBP
- Report
- April 2023
- 111 Pages
Global
From €4201EUR$4,750USD£3,627GBP
- Report
- January 2022
- 117 Pages
Global
From €4201EUR$4,750USD£3,627GBP
- Report
- January 2022
- 120 Pages
Global
From €4201EUR$4,750USD£3,627GBP
- Report
- November 2023
- 245 Pages
Global
From €3935EUR$4,450USD£3,398GBP
- Report
- November 2023
- 420 Pages
Global
From €3935EUR$4,450USD£3,398GBP
- Report
- December 2023
- 143 Pages
Global
From €3148EUR$3,560USD£2,718GBP
€3935EUR$4,450USD£3,398GBP
- Report
- April 2020
- 115 Pages
Global
From €2589EUR$2,928USD£2,236GBP
€3237EUR$3,660USD£2,795GBP
- Report
- February 2024
- 115 Pages
Global
From €4201EUR$4,750USD£3,627GBP
- Report
- February 2024
- 111 Pages
Global
From €4201EUR$4,750USD£3,627GBP
- Report
- April 2023
- 110 Pages
Global
From €4201EUR$4,750USD£3,627GBP
- Report
- August 2024
- 139 Pages
Global
From €2211EUR$2,500USD£1,909GBP
- Report
- July 2024
- 147 Pages
Global
From €2211EUR$2,500USD£1,909GBP
- Report
- July 2024
- 161 Pages
Global
From €2211EUR$2,500USD£1,909GBP
- Report
- June 2024
- 146 Pages
Global
From €2211EUR$2,500USD£1,909GBP
- Report
- June 2025
- 250 Pages
Japan
From €2466EUR$2,789USD£2,130GBP

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders.
The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more